Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396

6533b855fe1ef96bd12affe1

RESEARCH PRODUCT

Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404]

Melissa Matz Michel Coleman Helena Carreira Diego Salmerã³n Maria Dolores Chirlaque Claudia Allemani S Bouzbid M Hamdi-chérif Z Zaidi E Bah R Swaminathan Sh Nortje Mm El Mistiri S Bayo B Malle Ss Manraj R Sewpaul-sungkur A Fabowale Oj Ogunbiyi D Bradshaw Nim Somdyala Dc Stefan M Abdel-rahman L Jaidane M Mokni I Kumcher F Moreno Ms González Ea Laura Sb Espinola Gh Calabrano B Carballo Quintero R Fita Da Garcilazo Pl Giacciani Mc Diumenjo Wd Laspada Ma Green Mf Lanza Sg Ibañez Ca Lima E Lobo De Oliveira C Daniel C Scandiuzzi Pcf De Souza Cd Melo K Del Pino C Laporte Mp Curado Jc De Oliveira Cla Veneziano Db Veneziano Mrdo Latorre Lf Tanaka G Azevedo E. Silva Jc Galaz Ja Moya Da Herrmann S Vargas Vm Herrera Cj Uribe Le Bravo Ne Arias-ortiz Dm Jurado Mc Yépez Yh Galán P Torres F Martínez-reyes Ml Pérez-meza L Jaramillo R Quinto P Cueva Jg Yépez Cr Torres-cintrón G Tortolero-luna R Alonso E Barrios C Nikiforuk L Shack Aj Coldman Rr Woods G Noonan D Turner E Kumar B Zhang Fr Mccrate S Ryan H Hannah Rad Dewar M Macintyre A Lalany M Ruta L Marrett De Nishri C Mcclure Ka Vriends C Bertrand R Louchini K Robb H Stuart-panko S Demers S Wright Jt George X Shen Jt Brockhouse Dk O'brien Kc Ward L Almon J Bates R Rycroft L Mueller C Phillips H Brown B Cromartie Ag Schwartz F Vigneau Ja Mackinnon B Wohler Ar Bayakly Ca Clarke Sl Glaser D West Md Green By Hernandez Cj Johnson D Jozwik Me Charlton Cf Lynch B Huang Tc Tucker D Deapen L Liu Mc Hsieh Xc Wu K Stern St Gershman Rc Knowlton J Alverson Ge Copeland Db Rogers D Lemons Ll Williamson M Hood Gm Hosain Jr Rees Ks Pawlish A Stroup C Key C Wiggins Ar Kahn Mj Schymura G Leung C Rao L Giljahn B Warther A Pate M Patil Ss Schubert Jj Rubertone Sj Slack Jp Fulton Dl Rousseau Janes Ta: Schwartz Sm Sw Bolick Dm Hurley J Richards Ma Whiteside Lm Nogueira K Herget C Sweeney J Martin S Wang Dg Harrelson Mb Keitheri Cheteri S Farley Ag Hudson R Borchers L Stephenson Jr Espinoza Hk Weir Bk Edwards N Wang L Yang Js Chen Gh Song Xp Gu P Zhang Hm Ge Dl Zhao Jh Zhang Fd Zhu Jg Tang Y Shen J Wang Ql Li Xp Yang J Dong W Li Lp Cheng Jg Chen Qh Huang Sq Huang Gp Guo K Wei Wq Chen H Zeng Av Demetriou P Pavlou Wk Mang Kc Ngan R Swaminathan Ac Kataki M Krishnatreya Pa Jayalekshmi P Sebastian Sd Sapkota Y Verma A Nandakumar E Suzanna L Keinan-boker Bg Silverman H Ito H Nakagawa M Hattori Y Kaizaki H Sugiyama M Utada K Katayama H Narimatsu S Kanemura T Koike I Miyashiro M Yoshii I Oki A Shibata T Matsuda O Nimri A Ab Manan N Bhoo-pathy S Tuvshingerel O Chimedsuren Ahm Al Khater Mm El Mistiri H Al-eid Kw Jung Yj Won Cj Chiang Ms Lai K Suwanrungruang S Wiangnon K Daoprasert D Pongnikorn Sl Geater H Sriplung S Eser Ci Yakut M Hackl H Mühlböck W Oberaigner Aa Zborovskaya Ov Aleinikova K Henau L Van Eycken N Dimitrova Z Valerianova M ŠEkerija M Zvolský G Engholm H Storm K Innos M Mägi N Malila K Seppä J Jégu M Velten E Cornet X Troussard Am Bouvier J Faivre Av Guizard V Bouvier G Launoy P Arveux M Maynadié M Mounier E Fournier As Woronoff M Daoulas J Clavel S Le Guyader-peyrou A Monnereau B Trétarre M Colonna A Cowppli-bony F Molinié S Bara D Degré O Ganry B Lapôtre-ledoux P Grosclaude J Estève F Bray M Piñeros F Sassi R Stabenow A Eberle C Erb A Nennecke J Kieschke E Sirri H Kajueter K Emrich Sr Zeissig B Holleczek N Eisemann A Katalinic H Brenner Ra Asquez V Kumar Ej ÓLafsdóttir L Tryggvadóttir H Comber Pm Walsh H Sundseth E Devigili G Mazzoleni A Giacomin F Bella M Castaing A Sutera G Gola S Ferretti D Serraino A Zucchetto R Lillini M Vercelli S Busco F Pannozzo S Vitarelli P Ricci C Pascucci M Autelitano C Cirilli M Federico M Fusco Mf Vitale M Usala R Cusimano W Mazzucco M Michiara P Sgargi Mm Maule C Sacerdote R Tumino E Di Felice M Vicentini F Falcini L Cremone M Budroni R Cesaraccio Ml Contrino F Tisano Ac Fanetti S Maspero G Candela T Scuderi Ma Gentilini S Piffer S Rosso L Sacchetto A Caldarella F La Rosa F Stracci P Contiero G Tagliabue Ap Dei Tos M Zorzi R Zanetti P Baili F Berrino G Gatta M Sant R Capocaccia R De Angelis E Liepina A Maurina G Smailyte D Agius N Calleja S Siesling O Visser S Larønningen B Møller A Dyzmann-sroka M Trojanowski S Góźdż R Mężyk M Grądalska-lampart Au Radziszewska Ja Didkowska U Wojciechowska J Błaszczyk K Kępska M Bielska-lasota K Kwiatkowska G Forjaz Ra Rego J Bastos Ma Silva L Antunes Mj Bento A Mayer-da-silva A Miranda D Coza Ai Todescu My Valkov J Adamcik C Safaei Diba M Primic-žakelj T ŽAgar J Stare E Almar A Mateos Jr Quirós J Bidaurrazaga N Larrañaga Jm Díaz García Ai Marcos R Marcos-gragera Ml Vilardell Gil E Molina Mj Sánchez P Franch Sureda M Ramos Montserrat Md Chirlaque C Navarro Ee Ardanaz Cc Moreno-iribas R Fernández-delgado R Peris-bonet J Galceran S Khan M Lambe B Camey C Bouchardy M Usel Sm Ess C Herrmann Jl Bulliard M Maspoli-conconi H Frick Ce Kuehni M Schindler A Bordoni A Spitale A Chiolero I Konzelmann Si Dehler Kl Matthes J Rashbass Ca Stiller D Fitzpatrick A Gavin F Bannon Rj Black Dh Brewster Dw Huws C White P Finan C Allemani A Bonaventure H Carreira Mp Coleman V Di Carlo R Harewood K Liu M Matz L Montel M Nikšić B Rachet N Sanz D Spika R Stephens M Peake E Chalker L Newman D Baker Mj Soeberg J Aitken C Scott Bc Stokes A Venn H Farrugia Gg Giles T Threlfall D Currow H You J Hendrix C. Lewis

subject

0301 basic medicine Gynecology medicine.medical_specialty business.industry Published Erratum Obstetrics and Gynecology Library science Settore MED/42 - Igiene Generale E Applicata 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Oncology Editorial team 030220 oncology & carcinogenesis medicine business Stage at diagnosis

description

Objective. Ovarian cancer comprises several histological groups with widely differing levels of survival. We aimed to explore international variation in survival for each group to help interpret international differences in survival from all ovarian cancers combined. We also examined differences in stage-specific survival. Methods. The CONCORD programme is the largest population-based study of global trends in cancer survival, including data from 60 countries for 695,932 women (aged 15–99 years) diagnosed with ovarian cancer during 1995–2009. We defined six histological groups: type I epithelial, type II epithelial, germ cell, sex cord-stromal, other specific non-epithelial and non-specific morphology, and estimated age-standardised 5-year net survival for each country by histological group. We also analysed data from67 cancer registries for 233,659 women diagnosed from 2001 to 2009, for whom information on stage at diagnosis was available. We estimated agestandardised 5-year net survival by stage at diagnosis (localised or advanced). Results. Survival fromtype I epithelial ovarian tumours for women diagnosed during 2005–09 ranged from40 to 70%. Survival from type II epithelial tumours was much lower (20–45%). Survival fromgermcell tumours was higher than that of type II epithelial tumours, but also varied widely between countries. Survival for sex-cord stromal tumours was higher than for the five other groups. Survival from localised tumours was much higher than for advanced disease (80% vs. 30%). Conclusions. There is wide variation in survival between histological groups, and stage at diagnosis remains an important factor in ovarian cancer survival. International comparisons of ovarian cancer survival should incorporate histology.

year	journal	country	edition	language
2017-12-01	Gynecologic Oncology

https://doi.org/10.1016/j.ygyno.2017.06.033